Donald A Bergstrom's Net Worth

$11.6 Million

Estimate Recalculated Nov 1, 2024 06:31AM EST

Who is Donald A Bergstrom?

Donald A Bergstrom has an estimated net worth of $11.6 Million. This is based on reported shares across multiple companies, which include Relay Therapeutics, Inc., Fusion Pharmaceuticals Inc., and Mersana Therapeutics, Inc..

SEC CIK

Donald A Bergstrom's CIK is 0001709772

Past Insider Trading and Trends

2022 was Donald A Bergstrom's most active year for acquiring shares with 18 total transactions. Donald A Bergstrom's most active month to acquire stocks was the month of December. 2022 was Donald A Bergstrom's most active year for disposing of shares, totalling 39 transactions. Donald A Bergstrom's most active month to dispose stocks was the month of May. 2021 saw Donald A Bergstrom paying a total of $174,037.04 for 198,239 shares, this is the most they've acquired in one year. In 2021 Donald A Bergstrom cashed out on 173,079 shares for a total of $4,353,062.62, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Relay Therapeutics, Inc. (RLAY) Snapshot price: $6.29

President, R&D

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.51%
-2.69K
$6.06
-$16,289.28
520.75K
Oct 28
Form 4
-0.51%
-2.70K
$8.85
-$23,877.30
524.08K
Jul 29
Form 4
-0.12%
-648.00
$6.26
-$4,056.48
526.78K
Jun 27
Form 4
-0.51%
-2.69K
$6.38
-$17,136.68
527.43K
Apr 29
Form 4
-0.14%
-765.00
$7.70
-$5,890.50
530.11K
Mar 27
Form 4
-0.60%
-3.18K
$9.64
-$30,635.92
530.88K
Jan 29
Form 4
+128.17%
300K
—
—
534.06K
Jan 16
Form 4
-0.42%
-977.00
$11.51
-$11,245.27
234.06K
Dec 27
Form 4
-1.45%
-3.45K
$6.03
-$20,809.53
235.03K
Oct 30
Form 4
+0.12%
580
$9.53
$7,684.80
480.3K
Jun 30 - Sep 27
Form 4
-1.12%
-2.68K
$11.80
-$31,659.40
237.9K
Jul 28
Form 4
-0.27%
-647.00
$12.12
-$7,841.64
240.59K
Jun 27
Form 4/A
-1.17%
-2.85K
$11.16
-$31,806.00
241.23K
Apr 28
Form 4
-0.57%
-1.38K
$11.16
-$15,434.28
242.7K
Apr 28
Form 4
-0.31%
-763.00
$15.36
-$11,719.68
244.08K
Mar 27
Form 4
-0.58%
-1.43K
$21.56
-$30,809.24
244.85K
Jan 30
Form 4
+186.75%
160.39K
—
—
246.28K
Jan 17
Form 4
-1.13%
-980.00
$14.49
-$14,200.20
85.89K
Dec 27
Form 4
-2.05%
-1.82K
$13.33
-$188,178.18
86.87K
Scheduled
Oct 28 - Nov 1
Form 4
—
0
$13.28
-$146,480.00
88.68K
Scheduled
Oct 3
Form 4
-1.09%
-976.00
$22.73
-$22,184.48
88.68K
Sep 27
Form 4
—
0
$17.06
-$647,000.00
89.66K
Scheduled
Sep 8
Form 4
—
0
$14.79
-$104,566.00
89.66K
Scheduled
Sep 2
Form 4
—
0
$13.60
-$153,495.00
89.66K
Scheduled
Sep 1
Form 4
—
0
$14.56
-$313,200.00
89.66K
Scheduled
Aug 24
Form 4
—
0
$12.06
-$127,040.00
89.66K
Scheduled
Aug 5
Form 4
-2.01%
-1.83K
$21.27
-$39,030.45
89.66K
Jul 28
Form 4
—
0
$12.06
-$127,040.00
91.49K
Scheduled
Jul 6
Form 4
-1.08%
-1.00K
$12.08
-$147,329.69
91.49K
Scheduled
Jun 24 - Jun 27
Form 4
-1.92%
-1.81K
$14.43
-$312,807.27
92.49K
Scheduled
Apr 28 - May 2
Form 4
—
0
$17.22
-$471,600.00
94.3K
Scheduled
Apr 1
Form 4
-0.66%
-622.00
$29.87
-$18,579.14
94.3K
Mar 29
Form 4
—
0
$17.06
-$258,800.00
94.93K
Scheduled
Mar 24
Form 4
—
0
$14.56
-$208,800.00
94.93K
Scheduled
Mar 10
Form 4
—
0
$14.00
-$158,080.00
94.93K
Scheduled
Mar 1
Form 4
-13.64%
-14.99K
$12.53
-$448,616.92
94.93K
Scheduled
Feb 22
Form 4
+144.43%
64.95K
—
—
109.92K
Jan 27
Form 4
-1.42%
-649.00
$33.10
-$21,481.90
44.97K
Dec 27
Form 4
-39.67%
-30.00K
$34.15
-$1,024,500.00
45.62K
Scheduled
Oct 15
Form 4
-0.85%
-646.00
$36.87
-$23,818.02
75.62K
Sep 27
Form 4
-1.26%
-976.00
$35.81
-$34,950.56
76.27K
Jun 28
Form 4
—
0
$18.93
-$1,251,630.46
77.24K
Scheduled
Jun 16
Form 4
-42.17%
-56.32K
$32.36
-$1,822,644.64
77.24K
Scheduled
Apr 16
Form 4
+35.51%
35K
—
—
133.56K
Mar 26
Form 4
—
0
—
—
0
Dec 11
Form 3
—
0
—
—
0
No matching records found

Fusion Pharmaceuticals Inc. (FUSN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Apr 1
Form 3
—
0
—
—
0
No matching records found

Mersana Therapeutics, Inc. (MRSN) Snapshot price: $1.35

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 2
Form 3
—
0
—
—
0
No matching records found